Oncotelic Therapeutics (OTLC) Shares Outstanding (Diluted) (2019 - 2026)
Oncotelic Therapeutics' Shares Outstanding (Diluted) was 467.91 million in Q2 2026, up 3.3% from 452.81 million a year earlier.
Powered by 
Analysis
Oncotelic Therapeutics (OTLC) Shares Outstanding (Diluted) (2019 - 2026) Analysis & Trends
For FY2025, Shares Outstanding (Diluted) at Oncotelic Therapeutics came in at 422.23 million, up 4.4% from FY2024.
- Shares Outstanding (Diluted) shows a five-year compound annual growth rate of 34.8% (FY2020 to FY2025).
- In earlier years, Shares Outstanding (Diluted) was 404.4 million in FY2024 (+2.1%), 396.17 million in FY2023 (-13.4%), 457.3 million in FY2022 (+50.9%) and 303.08 million in FY2021 (+219.9%).
- The Q2 2026 figure marks the highest quarterly Shares Outstanding (Diluted) in data going back to Q2 2019.
- The best year-over-year quarter for Shares Outstanding (Diluted) over five years was Q3 2021 (growth of 291.0%); the worst was Q4 2023 (a decline of 13.4%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,109.83 Bn | 1,078.42 Bn | 19.71 Bn | 893.70 Mn |
| 2 | Johnson & Johnson | 610.61 Bn | 529.14 Bn | 17.26 Bn | 2.44 Bn |
| 3 | AbbVie | 500.66 Bn | 473.77 Bn | 12.70 Bn | 1.77 Bn |
| 4 | Merck | 354.64 Bn | 309.02 Bn | 12.21 Bn | 2.47 Bn |
| 5 | Novartis Ag | 291.14 Bn | 255.13 Bn | 11.24 Bn | 1.96 Bn |
| 6 | Astrazeneca | 254.18 Bn | 227.87 Bn | 12.86 Bn | 1.56 Bn |
| 7 | Amgen | 229.46 Bn | 184.86 Bn | 7.24 Bn | 544.00 Mn |
| 8 | Gilead Sciences | 190.33 Bn | 164.53 Bn | 6.22 Bn | 1.24 Bn |
| 9 | Pfizer | 167.92 Bn | 114.57 Bn | 10.94 Bn | 5.70 Bn |
| 10 | Oncotelic Therapeutics | 8.28 Mn | 7.42 Mn | - | 467.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 467.91 Mn |
| Dec 31, 2025 | 422.23 Mn |
| Sep 30, 2025 | 452.81 Mn |
| Jun 30, 2025 | 452.81 Mn |
| Mar 31, 2025 | 407.42 Mn |
| Dec 31, 2024 | 404.40 Mn |
| Sep 30, 2024 | 407.29 Mn |
| Jun 30, 2024 | 401.60 Mn |
| Mar 31, 2024 | 399.38 Mn |
| Dec 31, 2023 | 396.17 Mn |
| Sep 30, 2023 | 397.78 Mn |
| Jun 30, 2023 | 392.36 Mn |
| Mar 31, 2023 | 392.36 Mn |
| Dec 31, 2022 | 457.30 Mn |
| Sep 30, 2022 | 386.75 Mn |
| Jun 30, 2022 | 418.76 Mn |
| Mar 31, 2022 | 303.08 Mn |
| Dec 31, 2021 | 303.08 Mn |
| Sep 30, 2021 | 370.44 Mn |
| Jun 30, 2021 | 369.55 Mn |
API Access
Oncotelic Therapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=OTLC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "OTLC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=OTLC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();